CAS 1620479-63-1

MK-6169

Description:

MK-6169, also known by its CAS number 1620479-63-1, is a chemical compound that has been studied primarily for its potential therapeutic applications. It is classified as a selective antagonist of the cannabinoid receptor type 1 (CB1), which plays a significant role in various physiological processes, including appetite regulation, pain sensation, and mood. The compound's structure features a unique arrangement of functional groups that contribute to its binding affinity and specificity for the CB1 receptor. Research indicates that MK-6169 may have implications in the treatment of metabolic disorders, obesity, and related conditions by modulating the endocannabinoid system. Additionally, its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are critical for understanding its efficacy and safety profile in clinical settings. As with many investigational drugs, ongoing studies are essential to fully elucidate its therapeutic potential and any associated side effects.

Formula: C₅₄H₆₂FN₉O₈S

Synonyms:

• MK-6169
• Carbamic acid, N-[2-[(2S)-2-[5-[6-(5-cyclopropyl-2-thienyl)-1-fluoro-3-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]-2-oxo-1-(tetrahydro-2,2-dimethyl-2H-pyran-4-yl)ethyl]-, m...

MK-6169

CAS: 1620479-63-1

MK-6169 is an effective Pan-Genotype Hepatitis C Virus NS5A inhibitor. It also has Optimized Activity against Common Resistance-Associated Substitutions.

Formula: C₅₄H₆₂FN₉O₈S

Purity: 98%

Color and Shape: Solid

Molecular weight: 1016.2

Ref: TM-T24476